|
|
ECOG Clinical Trials in Myeloma For Newly-Diagnosed Patients
By Morie A. Gertz, MD
A Randomized Phase III Trial of Thalidomide Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma (E1A00)
A new trial (E4A03) just opening to look at Revlimid vs. Thalidomide and standard dose vs. lower dose Dexamethasone
|
|
|
back
print
related articles